Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Core Viewpoint - Arrowhead Pharmaceuticals, Inc. has announced inducement grants to 78 new employees, which will provide them with a total of 141,310 restricted stock units as part of their employment agreement [1] Group 1 - The inducement grants were approved by the Company's Board of Directors on December 12, 2025 [1] - The grants are made under Rule 5635(c)(4) of the NASDAQ Listing Rules [1] - These grants are outside the Company's stockholder-approved equity incentive plans [1]